Literature DB >> 8139007

Human immunodeficiency virus type 1 Rev-responsive element RNA binds to host cell-specific proteins.

R R Shukla1, P L Kimmel, A Kumar.   

Abstract

RNase protection-gel retention studies show human host cell-specific ribonucleoprotein complexes with human immunodeficiency virus type 1 Rev-responsive element (RRE) RNA. Nuclear proteins from rodent or murine cells appear to lack the ability to form these complexes. Human-mouse somatic cell hybrids retaining a single human chromosome, either 6 or 12, form the RRE-nuclear-protein complexes. One of the complexes requires the entire RRE RNA, while the other needs RRE RNA stem-loops 1 and 2 only. Two major proteins with molecular masses of 120 and 62 kDa specifically bind to RRE RNA. Rodent cells (CHO) either lack or contain small amounts of these RRE-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139007      PMCID: PMC236698     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

2.  HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region.

Authors:  S Heaphy; C Dingwall; I Ernberg; M J Gait; S M Green; J Karn; A D Lowe; M Singh; M A Skinner
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

3.  Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides.

Authors:  D J Chin
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 4.  Messenger RNA transport and HIV rev regulation.

Authors:  D D Chang; P A Sharp
Journal:  Science       Date:  1990-08-10       Impact factor: 47.728

5.  Secondary structure is the major determinant for interaction of HIV rev protein with RNA.

Authors:  H S Olsen; P Nelbock; A W Cochrane; C A Rosen
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

6.  HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.

Authors:  M H Malim; L S Tiley; D F McCarn; J R Rusche; J Hauber; B R Cullen
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

7.  Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells.

Authors:  M Newstein; E J Stanbridge; G Casey; P R Shank
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells.

Authors:  B Mermer; B K Felber; M Campbell; G N Pavlakis
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

9.  Binding of a host cell nuclear protein to the stem region of human immunodeficiency virus type 1 trans-activation-responsive RNA.

Authors:  M P Rounseville; A Kumar
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.

Authors:  C E Hart; C Y Ou; J C Galphin; J Moore; L T Bacheler; J J Wasmuth; S R Petteway; G Schochetman
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

View more
  5 in total

1.  Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

Authors:  S W Lee; H F Gallardo; E Gilboa; C Smith
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

2.  Restriction of human immunodeficiency virus type 1 Rev function in murine A9 cells involves the Rev C-terminal domain.

Authors:  Sandra M P Marques; Jean-Luc Veyrune; Ram R Shukla; Ajit Kumar
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  Human chromosome 6- and 11-encoded factors support human immunodeficiency virus type 1 Rev function in A9 cells.

Authors:  R R Shukla; S M Marques; P L Kimmel; A Kumar
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.

Authors:  T Nakaya; S Iwai; K Fujinaga; Y Sato; E Otsuka; K Ikuta
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes.

Authors:  E Ludwig; F C Silberstein; J van Empel; V Erfle; M Neumann; R Brack-Werner
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.